[1]
|
Dusing, P., Zietzer, A., Goody, P.R., et al. (2021) Vascular Pathologies in Chronic Kidney Disease: Pathophysiological Mechanisms and Novel Therapeutic Approaches. Journal of Molecular Medicine, 99, 335-348.
https://doi.org/10.1007/s00109-021-02037-7
|
[2]
|
Roth, G.A., Mensah, G.A., Johnson, C.O., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology, 76, 2982-3021.
|
[3]
|
《中国心血管健康与疾病报告》编写组. 《中国心血管健康与疾病报告2021》概述[J]. 中国心血管病研究, 2022, 20(7): 577-596.
|
[4]
|
Valdivielso, J.M., Rodriguez-Puyol, D., Pascual, J., et al. (2019) Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different? Arteriosclerosis, Thrombosis, and Vascular Biology, 39, 1938-1966.
https://doi.org/10.1161/ATVBAHA.119.312705
|
[5]
|
Loftus, T.J., Filiberto, A.C., Ozrazgat-Baslanti, T., et al. (2021) Cardiovascular and Renal Disease in Chronic Critical Illness. Journal of Clinical Medicine, 10, Article 1601. https://doi.org/10.3390/jcm10081601
|
[6]
|
Lopau, K. and Wanner, C. (2021) Treatment Rationale for Coronary Heart Disease in Advanced CKD. Herz, 46, 221-227. https://doi.org/10.1007/s00059-021-05025-2
|
[7]
|
Zhang, X., Hu, L. and Zheng, W. (2018) Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coro-nary Syndrome Patients with Renal Dysfunction. Scientific Reports, 8, Article No. 2283.
https://doi.org/10.1038/s41598-018-20651-3
|
[8]
|
Liao, G.Z., Li, Y.M., Bai, L., Ye, Y.Y. and Peng, Y. (2021) Re-vascularization vs. Conservative Medical Treatment in Patients with Chronic Kidney Disease and Coronary Artery Dis-ease: A Meta-Analysis. Frontiers in Cardiovascular Medicine, 8, Article 818958. https://doi.org/10.3389/fcvm.2021.818958
|
[9]
|
Raggi, P. (2017) Cardiovascular Disease: Coronary Artery Calcifi-cation Predicts Risk of CVD in Patients with CKD. Nature Reviews Nephrology, 13, 324-326. https://doi.org/10.1038/nrneph.2017.61
|
[10]
|
Sakaguchi, Y., Hamano, T., Obi, Y., et al. (2019) A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD. Journal of the American Society of Nephrology, 30, 1073-1085.
https://doi.org/10.1681/ASN.2018111150
|
[11]
|
Nelson, A.J., Raggi, P., Wolf, M., et al. (2020) Targeting Vascular Calcification in Chronic Kidney Disease. JACC: Basic to Translational Science, 5, 398-412. https://doi.org/10.1016/j.jacbts.2020.02.002
|
[12]
|
Mori, H., Torii, S., Kutyna, M., et al. (2018) Coronary Artery Calcification and Its Progression: What Does It Really Mean? JACC: Cardiovascular Imaging, 11, 127-142. https://doi.org/10.1016/j.jcmg.2017.10.012
|
[13]
|
Sarnak, M.J., Amann, K., Bangalore, S., et al. (2019) Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. Journal of the American College of Car-diology, 74, 1823-1838.
|
[14]
|
杨爽, 刘锋, 李淼, 等. 慢性肾脏病患者微炎症致动脉粥样硬化的机制研究进展[J]. 中国实验诊断学, 2020, 24(3): 530-532.
|
[15]
|
Zanoli, L., Lentini, P., Briet, M., et al. (2019) Arterial Stiffness in the Heart Disease of CKD. Journal of the American Society of Nephrology, 30, 918-928. https://doi.org/10.1681/ASN.2019020117
|
[16]
|
Baaten, C., Vondenhoff, S. and Noels, H. (2023) Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients with Chronic Kidney Disease. Circulation Research, 132, 970-992.
https://doi.org/10.1161/CIRCRESAHA.123.321752
|
[17]
|
Li, H., Li, M., Liu, C., et al. (2023) Causal Effects of Systemic Inflammatory Regulators on Chronic Kidney Diseases and Renal Function: A Bidirectional Mendelian Ran-domization Study. Frontiers in Immunology, 14, Article 1229636.
https://doi.org/10.3389/fimmu.2023.1229636
|
[18]
|
Dai, Z. and Zhang, X. (2023) Pathophysiology and Clinical Im-pacts of Chronic Kidney Disease on Coronary Artery Calcification. Journal of Cardiovascular Development and Disease, 10, Article 207.
https://doi.org/10.3390/jcdd10050207
|
[19]
|
Roumeliotis, S., Mallamaci, F. and Zoccali, C. (2020) Endothelial Dys-function in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update. Journal of Clinical Medicine, 9, Article 2359.
https://doi.org/10.3390/jcm9082359
|
[20]
|
Laville, S.M., Couturier, A., Lambert, O., et al. (2022) Urea Levels and Cardiovascular Disease in Patients with Chronic Kidney Disease. Nephrology Dialysis Transplantation, 38, 184-192.
|
[21]
|
Six, I., Flissi, N., Lenglet, G., et al. (2020) Uremic Toxins and Vascular Dysfunction. Toxins, 12, Article 404.
https://doi.org/10.3390/toxins12060404
|
[22]
|
El Chamieh, C., Liabeuf, S. and Massy, Z. (2022) Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings? Toxins, 14, Article 280.
https://doi.org/10.3390/toxins14040280
|
[23]
|
李天力, 王显, 李本志, 等. 冠心病伴慢性肾功能不全病人不同中医证型的冠状动脉病变特征分析[J]. 中西医结合心脑血管病杂志, 2022, 20(24): 4425-4428.
|
[24]
|
Virani, S.S., Alonso, A., Benjamin, E.J., et al. (2020) Heart Disease and Stroke Statistics-2020 Update: A Report from the American Heart Association. Circulation, 141, e139-e596.
|
[25]
|
Kyriakidis, N.C., Cobo, G., Dai, L., Lindholm, B. and Stenvinkel, P. (2021) Role of Uremic Toxins in Early Vascular Ageing and Calcification. Toxins, 13, Article 26. https://doi.org/10.3390/toxins13010026
|
[26]
|
Wojtasińska, A., Frąk, W., Lisińska, W., et al. (2023) Novel Insights into the Molecular Mechanisms of Atherosclerosis. International Journal of Molecular Sciences, 24, Article 13434. https://doi.org/10.3390/ijms241713434
|
[27]
|
Castelli, R., Gidaro, A., Casu, G., et al. (2023) Aging of the Arterial System. International Journal of Molecular Sciences, 24, Article 6910. https://doi.org/10.3390/ijms24086910
|
[28]
|
邓仁生, 农盛雄. 老年冠心病合并肾功能不全行冠脉心脏介入治疗的临床研究[J]. 中国现代药物应用, 2019, 13(14): 26-28.
|
[29]
|
Giustino, G., Mehran, R., Serruys, P.W., et al. (2018) Left Main Revascularization with PCI or CABG in Patients with Chronic Kidney Disease: EXCEL Trial. Journal of the American College of Cardiology, 72, 754-765.
|
[30]
|
Li, Y., Hou, X., Xu, X., et al. (2022) Coronary Artery Bypass Grafting vs. Percutaneous Coronary In-tervention in Coronary Artery Disease Patients with Advanced Chronic Kidney Disease: A Chinese Single-Center Study. Frontiers in Surgery, 9, Article 1042186. https://doi.org/10.3389/fsurg.2022.1042186
|
[31]
|
Li, Y., Hou, X., Liu, T., et al. (2022) Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Propensity Score Matching Study. Frontiers in Cardiovascular Medicine, 9, Article 802181. https://doi.org/10.3389/fcvm.2022.802181
|
[32]
|
Gallo, M., Blitzer, D., Laforgia, P.L., et al. (2022) Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft for Left Main Coronary Artery Disease: A Meta-Analysis. The Journal of Thoracic and Cardiovascular Surgery, 163, 94-105.E115. https://doi.org/10.1016/j.jtcvs.2020.04.010
|
[33]
|
Song, B., Dai, D., Liu, S., et al. (2021) Optimal Timing of Coro-nary Angiograms for Patients with Chronic Kidney Disease: Association between the Duration of Kidney Dysfunction and SYNTAX Scores. Renal Failure, 43, 307-312.
https://doi.org/10.1080/0886022X.2021.1880936
|
[34]
|
Spertus, J.A., Jones, P.G., Maron, D.J., et al. (2020) Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. The New England Journal of Medicine, 382, 1619-1628.
https://doi.org/10.1056/NEJMoa1916374
|
[35]
|
Bangalore, S., Maron, D.J. and Hochman, J.S. (2020) Management of Coronary Disease in Patients with Advanced Kidney Disease. The New England Journal of Medicine, 383, 1091-1092. https://doi.org/10.1056/NEJMc2024023
|
[36]
|
Tasoudis, P.T., Varvoglis, D.N., Tzoumas, A., et al. (2022) Percuta-neous Coronary Intervention versus Coronary Artery Bypass Graft Surgery in Dialysis-Dependent Patients: A Pooled Meta-Analysis of Reconstructed Time-to-Event Data. Journal of Cardiac Surgery, 37, 3365-3373. https://doi.org/10.1111/jocs.16805
|
[37]
|
涂少文. 冠心病合并肾功能不全患者PCI术后回顾性分析[D]: [硕士学位论文]. 汕头: 汕头大学, 2022.
|
[38]
|
Golub Ilana, S., Termeie Orly, G., Kristo, S., et al. (2023) Major Global Coronary Artery Calcium Guidelines. JACC: Cardiovascular Imaging, 16, 98-117. https://doi.org/10.1016/j.jcmg.2022.06.018
|
[39]
|
Townsend, R.R. (2019) Arterial Stiffness in CKD: A Review. American Journal of Kidney Diseases, 73, 240-247.
https://doi.org/10.1053/j.ajkd.2018.04.005
|
[40]
|
陈珂, 聂振禹, 包蓓艳. 慢性肾脏病患者动脉粥样硬化相关生物标志物研究进展[J]. 浙江医学, 2020, 42(23): 2591-2593, 2598.
|